WINCHESTER – The Winchester District Memorial Hospital says it’s reached a “new milestone” as it starts clinical trials.
Clinical trials involve testing of treatments or drug options before they are used in general medical practice.
The first trial the hospital is tackling is part of an international study of a disorder that causes the heart muscle to stiffen and become weak.
Abnormal proteins from the liver build up in the heart chamber causing Transthyretin Amyloid Cardiomyopathy or ATTR-CM.
The study is sponsored by Pfizer.
Over the next three years WDMH will study how common it is when dealing with patients suffering from heart failure.